MELBOURNE and SAN DIEGO — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, announced that the Company will be presenting at the Biotech Showcase™ 2024, a premiere investor conference for life science companies, being held January 8-10, 2023, in San Francisco, CA.
The Company’s Managing Director and CEO, Dr. Isaac Bright, will deliver an in-person presentation, providing an overview of the company and an update on the Company’s latest development pipeline of MagSense® Imaging Agent Technologies, a groundbreaking category of molecularly targeted MRI Contrast Agents designed for the early cancer detection of solid tumors and metastases.
Imagion Biosystems | Dr. Isaac Bright Presentation details:
Date & Time: Monday, January 8, 2023, 11:30 A.M. (Pacific Time)
Place: Hilton San Francisco Union Square; Yosemite C
“We are delighted that Imagion Biosystems will be joining us in San Francisco and presenting at Biotech Showcase this year,” said Sara Demy, CEO of Demy-Colton. “Biotech Showcase is a prime opportunity for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of drug discovery.”
Registered attendees may attend the Company’s presentation in-person or view it via webcast through the Biotech Showcase platform. The presentation will also be uploaded on the Company’s website (https://imagionbiosystems.com/news/) after the session.
Investors interested in arranging a meeting with the Company’s management during the conference should contact casie.ost@imagionbio.com.
